Dr. Marina P. Gehring Meyers brings to ECIR her background as a research scientist, medical writer, and published author, with more than 10 years of experience in oncology and immuno-oncology research. During her career, she authored more than 10 manuscripts in peer-reviewed journals, including Cancer Discovery and Journal of Clinical Oncology. As a medical writer at ECIR, she joins her passion for writing and editing with her knowledge in oncology. She enjoys helping clients to create content that tells a story in their unique voice and elevates their brand.
Dr. Gehring Meyers completed her bachelor degree in biomedical sciences in Brazil and gained experience throughout her master’s and doctorate studies in cellular and molecular biology. During her doctoral studies, she was awarded a scholarship to go to Harvard Medical School, where she explored the effect of the CD39 enzyme deletion on radiotherapy immune response and contributed to the writing of a book chapter about purinergic signaling mechanisms involved in oncology, published in Frontiers in Anti-Cancer Drug Discovery. Before joining ECIR, she was working on a postdoctoral degree at SBP Medical Discovery Institute in San Diego, California. Throughout her career, Dr. Gehring Meyers coordinated multiple oncology-related projects and was involved in the study plan, data analysis, and manuscript publication. Dr. Gehring Meyers also completed a certificate in clinical trials and design and management from University of California San Diego.